These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3279381)

  • 1. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
    Goudard M; Regli P; Buffard Y; Gabriel B
    Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
    Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
    Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
    Hughes CE; Harris C; Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 May; 25(5):560-2. PubMed ID: 6329088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "In vitro" evaluation of Aspergillus susceptibility to antifungal agents.
    Viviani MA; Tortorano AM
    Ann Sclavo; 1982; 24(6):642-50. PubMed ID: 6320751
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
    Guinet R; Mazoyer MA
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
    Kantarcioğlu AS; Yucel A
    J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
    Denning DW; Hanson LH; Perlman AM; Stevens DA
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):21-34. PubMed ID: 1309690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal chemotherapy.
    Hoeprich PD
    Prog Drug Res; 1995; 44():87-127. PubMed ID: 7644668
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Skóra M; Bulanda M; Jagielski T
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
    Moore CB; Walls CM; Denning DW
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
    Fernández MS; Rojas FD; Cattana ME; Sosa Mde L; Iovannitti CA; Lass-Flörl C; Giusiano GE
    Antimicrob Agents Chemother; 2015; 59(6):3619-22. PubMed ID: 25824228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
    Bava AJ; Negroni R
    Rev Inst Med Trop Sao Paulo; 1989; 31(5):346-50. PubMed ID: 2560840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
    Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
    Yangco BG; Okafor JI; TeStrake D
    Antimicrob Agents Chemother; 1984 Apr; 25(4):413-6. PubMed ID: 6329078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.